Skip to content

Yuan Shi

6 papers in the library · 16 citations · publishing 2018-2026

Papers

Sort Most recent Most cited

Effects of psychedelics on subjective and objective sleep outcomes: A systematic review and exploratory meta-analysis

Therapeutic Advances in Psychopharmacology October 1, 2026 Xin Yang, Shuping Fang, Kejia Hu et al.

Background: Psychedelics, including classic psychedelics, 3,4-methylenedioxymethamphetamine (MDMA), and ketamine, are increasingly investigated for psychiatric disorders, but their effects on sleep remain unclear. Objectives: To systematically evaluate the effects of these interventions on subjective and objective sleep outcomes and summarize sleep-related adverse events. Design: A systematic...

Intestinal γδ T17-IL-17A signaling disrupts hippocampal mitophagy in stress-induced depression and is restored by arketamine.

Journal of Neuroinflammation December 18, 2025 Mengqi Han, Bing Xie, Yuan Yu et al.

Chronic stress precipitates depression, yet how gut-immune-brain interactions translate stress into mood pathology remains unclear. We tested the hypothesis that stress-primed small intestinal γδ T cells drive hippocampal mitochondrial dysfunction and depression-like behavior via interleukin-17A (IL-1A). In mice exposed to chronic restraint stress (CRS), we combined behavioral assays...

From default-mode to action-mode: biphasic network reconfiguration with meditation in schizophrenia

medRxiv November 20, 2025 Qing Wang, Lizhao Du, Jialing Sheng et al. preprint

Whether and how meditation benefits severe psychosis over clinically meaningful timescales remains unclear. We embedded longitudinal neuroimaging in an eight-month, parallel group randomized clinical trial (ChiCTR1800014913) of male inpatients (n=64) with schizophrenia receiving daily clinician-guided meditation plus rehabilitation versus rehabilitation alone. Meditation improved the symptoms...

Eight-month intensive meditation-based intervention improves refractory hallucinations and delusions and quality of life in male inpatients with schizophrenia: a randomized controlled trial.

Psychiatry and Clinical Neurosciences April 1, 2024 Ting Xue, Jialing Sheng, Hui Gao et al. 5 citations

This study investigated the impact of an 8-month daily-guided intensive meditation-based intervention (iMI) on persistent hallucinations/delusions and health-related quality of life (QoL) in male inpatients with schizophrenia with treatment-refractory hallucinations and delusions (TRHDs). A randomized controlled trial assigned 64 male inpatients with schizophrenia and TRHD equally to an 8-month...

DOI: 10.1111/pcn.13641 (opens in new tab) Full text (opens in new tab) Meditation‐based intervention Quality of life Randomized controlled trial Schizophrenia

The heart-brain axis: A proteomics study of meditation on the cardiovascular system of Tibetan Monks

EBioMedicine May 13, 2022 Ting Xue, Benjamin Chiao, Tianjiao Xu et al.

Summary Background There have been mixed reports on the beneficial effects of meditation in cardiovascular disease (CVD), which is widely considered the leading cause of death worldwide. Methods To clarify the role of meditation in modulating the heart-brain axis, we implemented an extreme phenotype strategy, i.e., Tibetan monks (BMI > 30) who practised 19.20 ± 7.82 years of meditation on...

Mindfulness meditation improves metabolic profiles in healthy and depressive participants

CNS Neuroscience & Therapeutics February 5, 2018 Ting Xue, Han Li, Meiti Wang et al. 11 citations

Recently, the increased prevalence of depression largely affects people's quality life and raises social suicide rate. Meanwhile, depression has been reported associated with lipid abnormalities, one of the major risks of cardiovascular disease and diabetes. 1 Hence, the improvement of lipid metabolism is of critical for depressive patients' health care. Meditation, an ancient mind training to...